Literature DB >> 1650697

Prevalence of antibodies to hepatitis C virus in blood donors and risk groups in Istanbul, Turkey.

O S Yenen, S Badur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1650697     DOI： 10.1007/bf01964417

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Non-A, non-B hepatitis and antibody to hepatitis C virus.

Authors:  J W Mosley; R D Aach; F B Hollinger; C E Stevens; L H Barbosa; G J Nemo; P V Holland; W H Bancroft; H J Zimmerman; G Kuo
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

Review 3.  Will the real hepatitis C stand up?

Authors: 
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

4.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728
  4 in total
  2 in total

1.  Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma.

Authors:  A Arican; T Sengezer; M Bozdayi; H Bozkaya; E Uçgül; D Dinçol; O Uzunalimoğlu
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

2.  The epidemiology of hepatitis C in Turkey.

Authors:  D L Thomas; R W Mahley; S Badur; E Palaoglu; T C Quinn
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.